Literature DB >> 31798733

Traditional and Non-traditional Clinical and Biochemical Risk Factors for Altered Kidney Function in Type II Diabetes mellitus Patients.

Violeta Valentina Gherdan1, Amorin Remus Popa1.   

Abstract

Background:Exploring the risk factors associated with increased albumin excretion is necessary in patients with type 2 diabetes mellitus, due to the fact that such patients are exposed to an increased risk of progression to diabetic kidney disease and that non-traditional newly emerging factors could be corrected in order to reduce the progression rate. Material and methods:218 patients with type 2 diabetes mellitus were investigated regarding their urinary albumin/creatinine ratio. Clinical and laboratory data was collected from them, with biochemical investigations including serum uric acid and serum 25-hydroxi-vitamin D (25-OH-vitamin D) measurements. The prevalence of traditional and non-traditional risk factors for increased albumin excretion rate (albumin/creatinine ratio>30 mg/g), hyperuricemia and 25-OH-vitamin D deficiency, was determined after dividing patients into two groups, one with microalbuminuria and the other one with micro- or macroalbuminuria.
Results: Of all patients, 104 (47.93%) had microalbuminuria, while 9.22% (20) presented macroalbuminuria. Poor glucose control (HbA1c .7%), female sex, hyperuricemia (uric acid .7 mg/dL), vitamin D deficiency (25-OH-vitamin D .50 nmol/L), hypertension (systolic hypertension or diastolic hypertension or hypertension treatment) and hypertriglyceridemia (triglycerides .150 mg/dL) had a statistically significant higher prevalence (p<0.05) in the 124 patients with microalbuminuria or macroalbuminuria compared to the 94 subjects wit normaoalbuminuria.
Conclusion: Glucose control, hypertension and dyslipidemia are relevant traditional risk factors for an altered kidney function defined as urinary albumin/creatinine ratio >30 mg/g. However, hyperuricemia and 25-OH-vitamin D deficiency are long time ignored factors that could play an important role in the progression towards diabetic kidney disease.

Entities:  

Year:  2019        PMID: 31798733      PMCID: PMC6861715          DOI: 10.26574/maedica.2019.14.3.203

Source DB:  PubMed          Journal:  Maedica (Buchar)        ISSN: 1841-9038


  14 in total

1.  Biochemistry and molecular cell biology of diabetic complications.

Authors:  M Brownlee
Journal:  Nature       Date:  2001-12-13       Impact factor: 49.962

2.  An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: the MicroAlbuminuria Prevalence (MAP) Study.

Authors:  A Y T Wu; N C T Kong; F A de Leon; C Y Pan; T Y Tai; V T F Yeung; S J Yoo; A Rouillon; M R Weir
Journal:  Diabetologia       Date:  2004-12-23       Impact factor: 10.122

3.  A longitudinal study of hypertension risk factors and their relation to cardiovascular disease: the Strong Heart Study.

Authors:  Wenyu Wang; Elisa T Lee; Richard R Fabsitz; Richard Devereux; Lyle Best; Thomas K Welty; Barbara V Howard
Journal:  Hypertension       Date:  2006-01-23       Impact factor: 10.190

4.  Low 25-hydroxyvitamin D levels and mortality in non-dialysis-dependent CKD.

Authors:  Sankar D Navaneethan; Jesse D Schold; Susana Arrigain; Stacey E Jolly; Anil Jain; Martin J Schreiber; James F Simon; Titte R Srinivas; Joseph V Nally
Journal:  Am J Kidney Dis       Date:  2011-08-04       Impact factor: 8.860

5.  Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial.

Authors:  Dick de Zeeuw; Rajiv Agarwal; Michael Amdahl; Paul Audhya; Daniel Coyne; Tushar Garimella; Hans-Henrik Parving; Yili Pritchett; Giuseppe Remuzzi; Eberhard Ritz; Dennis Andress
Journal:  Lancet       Date:  2010-11-06       Impact factor: 79.321

6.  Hyperuricemia contributes to the faster progression of diabetic kidney disease in type 2 diabetes mellitus.

Authors:  Vendula Bartáková; Katarína Kuricová; Lukáš Pácal; Zuzana Nová; Veronika Dvořáková; Martina Švrčková; Denisa Malúšková; Ivana Svobodová; Jitka Řehořová; Jan Svojanovský; Jindřich Olšovský; Jana Bělobrádková; Kateřina Kaňková
Journal:  J Diabetes Complications       Date:  2016-06-07       Impact factor: 2.852

7.  Justice Came to Hypertension Or Did It?

Authors:  Mircea Cinteza
Journal:  Maedica (Bucur)       Date:  2017-12

Review 8.  Stop chronic kidney disease progression: Time is approaching.

Authors:  Usama Abdel Azim Sharaf El Din; Mona Mansour Salem; Dina Ossama Abdulazim
Journal:  World J Nephrol       Date:  2016-05-06

9.  Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective.

Authors:  H-H Parving; J B Lewis; M Ravid; G Remuzzi; L G Hunsicker
Journal:  Kidney Int       Date:  2006-06       Impact factor: 10.612

Review 10.  Uric Acid and Diabetic Nephropathy Risk.

Authors:  Michael Mauer; Alessandro Doria
Journal:  Contrib Nephrol       Date:  2018-01-23       Impact factor: 1.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.